The substrate saturation and temperature-dependent kinetic properties of soluble and membrane-bound forms of acetylcholinestarase (A C h E ) from brain and butyrylcholinester ase (B C h E ) from heart and liver were examined. In simultaneous studies these parameters were also measured for A C h E in erythrocyte membranes and for B C h E in the serum from rat and humans. For both soluble and membrane-bound forms of the enzyme from the three tissues, two components were discernible. In the brain, K m of component I (high affinity) and component II (low affinity) was somewhat higher in membrane-bound form than that of the soluble form components, while the Vmax values were significantly higher by about five fold. In the heart, K m of component II was lower in membrane-bound form than in the soluble form, while Vmax for both the components was about four to six fold higher in the membrane-bound form. In the liver, Vmax was marginally higher for the two components of the membrane-bound enzyme; the K m only of component I was higher by a factor of 2. In the rat erythrocyte membranes three components of A C h E were present showing increasing values of K m and Vmax. In contrast, in the human erythrocyte membranes only two com po nents could be detected; the one corresponding to component II of rat erythrocyte mem branes was absent. In the rat serum two components of B C h E were present while the human serum was found to possess three components. Component I of the human serum was missing in the rat serum. Temperature kinetics studies revealed that the Arrhenius plots were biphasic for most of the systems except for human serum. Membrane binding of the enzyme resulted in decreased energy of activation with shift in phase transition temperature ( r t) to near physiological temperature.
Introduction
In the vertebrates two different enzymes hydrolyze acetylcholine. Acetylcholinesterase (AChE: E.C. 3.1.1.7) terminates the action of ace tylcholine at the post-synaptic membrane on neu romuscular junction. The second enzyme butyr ylcholinesterase (BC hE: E.C. 3.1.1.8), which is also called Cholinesterase, pseudocholinesterase (PChE) or non-specific Cholinesterase can also act on acetylcholine. The two enzymes differ with re spect to their substrate specficity as well as their reactivity with various selective inhibitors. Thus AChE hydrolyzes acetylcholine faster than any other Cholinesterase and is much less active on butyrylcholine. AChE also typically shows substrate inhibition at high substrate concentrations. BC hE, by contrast, preferentially acts on butyrylcholine, but also hydrolyzes acetylcholine. However BC hE is generally more active on synthetic substrates, propionylcholine or butyrylcholine. AChE is in hibited selectively by l,5-bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide (BW 284C51), while BC hE is selectively inhibited by 10-[2-diethylaminopropyl]-phenothiazine (ethopropazine) and isotetra monoisopropyl pyrophos phate tetramide (iso-OMPA). The two enzymes are widely distributed in all the vertebrate phyla and in a given organism the distribution of AChE and BC hE is tissue-specific (Chatonnet and Lockridge, 1989; Massoulie et al., 1993) .
Earlier researchers have reported on the K m and Vmax values of the cholinesterases from Tor pedo and mammalian tissues (Jagota, 1992; Lenz et al., 1984; Shuttleworth et al., 1990; Silver, 1974; Suhail and Rizvi, 1989) . However in view of the more recent information on the existence of mo lecular isoforms, which are present in the soluble and the membrane-bound forms (Bisso et a l., 1991; Massoulie et al., 1993) , and their tissue-specific dis tribution (Bisso et al., 1991; Chatonnet and Lockridge, 1989; Massoulie et al., 1993) , it is desirable to find out the kinetic properties of molecular iso forms themselves.
We have therefore carried out studies to il lustrate the kinetic properties of soluble and membrane-bound forms of AChE from brain and BC hE from heart and liver. In simultaneous studies we also measured these parameters for AChE in erythrocyte membrane preparations from rat and humans and for B C h E in the serum of the two species. The results of these experi ments are summarized in the present communica tion.
Materials and Methods

Chemicals
Acetylthiocholine iodide (A C TI), butyrylthiocholine iodide (B C T I) and ethopropazine hydro chloride (ETPZ.HC1) were purchased from Sigma Chemical Co., U SA. 5,5'-dithio-bis(2-nitrobenzoic acid) (D TN B) was purchased from SR L, India. All other chemicals were of analytical reagent grade and were purchased locally.
Anim al and human studies
For animal studies, adult male rats of CharlesFoster strain were used. The animals had free ac cess to food and water.
In human studies the blood was collected from normal healthy volunteers (both males and fe males; 2 5 -4 5 year old) by informed consent.
Isolation o f soluble and m em brane-bound form s o f cholinesterases
This was achieved essentially by following the procedure of Bisso et al. (1991) as described earlier (Khandkar et al., 1995) .
Briefly, the tissues (brain, heart and liver) from male adult rats were quickly removed after decap itation and placed in beakers containing chilled ( 0 -4 °C) 38 mM tris(hydroxymethyl)aminomethane (Tris)-HCl buffer pH 8.5. The tissues were re peatedly washed with the same buffer and 10% (w/v) homogenates were prepared using a PotterElvehjem type glass-teflon homogenizer. The ho mogenates were centrifuged at 100,000 x g for 1 h and the supernatant was carefully decanted. The supernatant served as the source of the soluble form of the enzyme. The pellet was resuspended by gentle homogenization in the same volume of 38 mM Tris-HCl buffer, pH 8.5 containing 0.25% Triton X 100 and subjected to a further centrifuga tion at 100,000xg for 1 h. The second supernatant thus obtained was used as the source of the membrane-bound enzyme. All the operations were car ried out at 0 -4 °C.
Preparation o f erythrocyte m em branes
Preparation of erythrocyte membranes was essentially according to the method of Hanahan and Ekholm (1978) .
Briefly, blood was collected in the presence of sodium citrate (final concentration 10 m M ) and was centrifuged at 475 xg for 8 min. Supernatant and the buffy coat overlying the red blood cell (R B C ) pellet was discarded and the pellet was washed twice with 0.9% NaCl. The washed RBC s were then subjected to hypotonic lysis in 14 m M Tris-HCl buffer pH 7.4 (Kumthekar and Katyare, 1992) and after centrifugation at 30,000x g for 35 min the supernatant was discarded. The pellet was washed repeatedly with the same buffer to ob tain the hemoglobin free membranes. The pellet was resuspended in the same buffer (ca. 1 mg pro tein/ml) and was used as the source of the enzyme.
Serum
The rat or human blood was allowed to aggre gate at room temperature and sera were collected after centrifugation in a clinical centrifuge.
Assay o f A C h E and B C h E activities
The AChE/BChE activities were determined essentially according to the procedure of Ellman et al. (1961) as described previously with some modifications (Khandkar et al., 1995) .
Thus for AChE activity determination, the assay system contained in a total volume of 1 ml: 100 m M potassium phosphate buffer pH 8.0, 0.32 m M DTNB, 0.1 mM ETPZ.HC1, and 10 to 50 jig protein of the soluble form or the membrane-bound form of the brain enzyme or erythrocyte membranes. For substrate kinetics studies the concentration of substrate i.e. ACTI was varied from 0.05 to 10 m M . Linear rate of reaction recorded over a period of 60 to 90 seconds at 37 °C was used for calculation of the rate of the reaction. ETPZ.HC1 was in eluded in the assay medium as the inhibitor of BChE.
For determination of BC hE activity the assay system was the same as above except that 0.05 m Tris-HCl buffer pH 8.0 replaced the potassium phosphate buffer, ETPZ.HC1 was omitted and BC TI was the substrate. 10 to 50 jig of protein served as the source of tissue enzymes, while for serum, 10 |il of rat serum and 20 jil of 1:10 diluted human serum were used as the source of enzyme.
In separate experiments we have ascertained that for the BC hE activity, better results are ob tained in 0.05 m Tris-HCl buffer pH 8.0, than in 0.1 m potassium phosphate buffer pH 8.0. DTN B solution was prepared by dissolving 13 mg DTN B + 5 mg N aH C 03 in 10 ml potassium phosphate or in Tris-HCl buffer for AChE and BC hE assays, respectively (Ellman et al., 1961) .
The data were analyzed by the Lineweaver Burk, Eadie-Hofstee and Eisenthal and CornishBowden methods for the determination of K m and Vmax (Dixon and Webb, 1979) . The values of K m and Vmax obtained by the three methods of analy sis were in close agreement and were averaged. The results are given as mean ± S.E. of the averaged values. The data were computer-ana lyzed employing Sigma Plot version 5.0.
Temperature kinetics studies
The enzyme activities were determined over a temperature range of 5 to 53 °C with optimum substrate concentration (5 m M ). The analysis of the data for determination of energies of activa tion for the high and the low temperature ranges (E l and E2, respectively) and phase transition temperature (T t) was according to Raison (1972) . All analyses were performed on computer em ploying Sigma Plot version 5.0 as described above.
Protein estimation was according to the pro cedure of Lowry et al. (1951) .
Statistical evaluation of the data was by Stu dents' t-test.
Results and Discussion
The typical Eadie-Hofstee plots for the soluble and membrane-bound enzymes from the three rat tissues are shown in Fig. 1 . It is evident that for all the samples tested there are two components of the enzymes; component I has low K m and low Vmax and component II has high K m and high Vmax-The values of K m and Vmax f°r the two com ponents of the soluble and the membrane-bound forms of the enzyme are given in Table I . Thus from the data in Table I it can be assumed that in the brain both the components of the membrane-bound form of AChE are characterized by higher values of K m and Vmax compared to their counterparts in the soluble fraction. Although the K m values were somewhat higher, the differences were not statistically significant. However, the Knax values for both the components were about 5 times higher and the differences were statisti cally highly significant. The higher Vmax values for both the components of the membrane-bound form of AChE in the brain would be consistent with its role in hydrolysis of the neurotransmitter acetylcholine at the synapse (Massoulie et al., 1993) . It may, however, be mentioned here that in our earlier studies (Khandkar et al., 1995) we were unable to delineate two components of the en zyme in the brain.
The predominant form of AChE in the brain is G4 which is preferentially presynaptic and mostly exposed on the external surface of the cell, al though the G2 and G1 forms are also present as minor components (Marquis and Fishman, 1985; Bon et al., 1991) . The G4 and G2 forms are known to be present in the membrane-bound as well as in the soluble form (Bisso et al., 1991) . The results of our present studies on the kinetic properties are consistent with and substantiate the above find ings. Firstly, we were able to show the presence of two components differing in their kinetic proper ties. Secondly, the higher values of Vmax for the membrane-bound form of the enzymes may sug gest that the concentration of membrane-bound form is substantially high, which emphasizes its physiological role. Besides, the results also suggest that membrane binding can significantly influence the kinetic properties of the enzyme, (e.g. also see Fig. 3 and Table III ).
The information on distribution of molecular isoforms of BC hE in the soluble and membranebound forms in the heart and liver is not available (Chatonnet and Lockridge, 1989; Massoulie et al., 1993) . However, our data on the K m and Vmax ( Fig. 1 and Table I ) would suggest the multiplicity of molecular isoforms in both the soluble and membrane-bound fraction also in these two tissues i.e. heart and liver.
The typical Eadie-Hofstee plots for erythrocyte membrane AChE and serum BC hE from rat and humans are shown in Fig. 2 . It can be noted that the R B C membranes from rat display the presence of 3 components of AChE with increasing values of K m and Vmax. In contrast, the human R BC membranes show presence of only two compo nents which correspond, to component I and com ponent III of the rat erythrocyte membranes respectively (Table II) . The rat serum includes two BC hE components (Fig. 2) . In contrast to this, the human serum contains three BC hE components with increasing values of K m and Vmax; compared with the human serum, in the rat serum compo nent I is absent (viz. see also Table II ) . It is also of interest to note that for any given component, the value of Vmax for both erythrocyte membrane AChE or serum B C hE were always higher in the human samples.
It is likely that the presence of multiple compo nent of AChE which we observe in the erythrocyte membranes may be attributed to the differential membrane locations and differential glycosylation of the enzyme and/or membrane components re ferred to above (Massoulie, 1993) . It also is rea sonable to expect that the R B C membranes from rats and humans will differ in their lipid/phospho lipid composition; the phospholipid composition of the R B C membrane in the two species is known to be widely different (Katewa, 1997; Labrouche et al., 1996; Zubay, 1993) . The observed differences in the kinetic properties of AChE in the erythro cyte membranes from human and rats may be thus attributed to these factors. The serum BC hE is believed to originate in the liver (Khoury et al., 1987) and in human plasma presence of monomers, dimers and tetramers called C l, C3 and C4 respectively has been re ported (Masson, 1979) . Our data which show pres ence of three components in human serum (Table   II) are consistent with the above observation (Masson, 1979) . However, our data point out that, in the rat serum the pattern is different in that there are only two components of BC hE. The function of BC hE in the tissues and serum is not clearly understood. From study of natural allelic variants, BC hE seems to be dispensable, while the circulating AChE activity is clearly vital (Massou lie, 1993; Tunek and Svensson, 1988) .
Nevertheless, our present studies have brought forth species-specific differences in AChE and BC hE distribution and kinetic properties, respec tively, in the erythrocyte membranes and serum.
The typical Arrhenius plots for the soluble and membrane-bound enzymes from rat tissues are shown in Fig. 3 from which it is apparent that in all the cases the Arrhenius plots are biphasic. The Table III values of E l, E2 and Tt are given in Table III , from which it can be concluded that the mem brane-bound form of AChE in the brain has about 4 0 -5 0 % lower values for E l and E2 with the Tt being close to physiological temperature; in the soluble enzyme the value of Tt was lowered by about 18 °C. Significance of this latter observation remains obscure. In the heart, the value of E2 was comparable for the membrane-bound and soluble forms of the enzymes, but the value of E l in the latter was somewhat low. The Tt was lowered by 7 °C in the membrane-bound form although the difference was not statistically significant.
For the soluble enzyme in the liver the value of E l was higher than E2. The picture was reversed for membrane-bound form which also displayed a 17 °C decrease in the Tt which was statistically highly significant.
The typical Arrhenius plots for erythrocyte membrane AChE and serum BC hE in the rat and humans are shown in Fig. 4 , from which it is evi dent that these plots were biphasic except for the human serum for which a monophasic plot was obtained. The values of E l , E2 and Tt as applica ble are given in Table IV from which it can be noted that for erythrocyte membrane AChE from both the sources the values for E l are about 2 times higher than those for E2 as was found earlier for the liver soluble enzyme (Table III) , and that the Tt was near physiological temper ature. For the rat serum BC hE, the value of E2 was about double that of E l with Tt occurring around 21 °C; for human serum the energy of acti vation was comparable with E l for rat serum with no phase transition being evident.
The Arrhenius plot analyses have brought into focus differences in the temperature kinetics of the soluble and membrane-bound forms of the en zymes from the tissues and erythrocyte mem branes. Seemingly the energies of activation are lower in the membrane-bound form of the en-physiological temperature. The results suggest that zymes (Table III) 24.4 ± 0.55
--------
The results are given as mean ± S.E. of the number of independent observa tions indicated in the parentheses. Enzyme activities were determined with opti mum substrate concentration (5 mM). ACTI was the substrate for the R B C membranes A C hE while for serum B C h E , BC TI was the substrate.
